West Palm Beach, FL, USA — BioTools Inc., a Florida-based pioneer in chiroptical spectroscopy and molecular characterization proudly announce the appointment of Denis Petrov as its new Chief Executive Officer.

Mr. Petrov brings more than two decades of leadership experience in technology, biotechnology, and identity management. He is best known as the cofounder and former CEO of IDScan.net, an Inc. 5000 company recognized as one of America’s

fastest-growingtechnology firms. His background in scaling innovative ventures, developing strategic partnerships, and commercializing advanced technologies will drive BioTools’ continued growth in spectroscopy instrumentation and analytical services.

“Denis brings a unique blend of entrepreneurial vision and operational discipline to BioTools,” said Dr. Rina Dukor, President and Co-Founder of BioTools Inc. “His experience building companies from startup to global scale will be invaluable as we enter the new era with the next-generation molecular characterization technologies and expand our contract analytical lab services to new markets and regions.

Under Petrov’s leadership, BioTools aims to strengthen its position as a premier provider of optical spectroscopy and software tools for structural analysis for the pharmaceutical, food technology, environmental and nanotechnology sectors. The company plans to enhance its customer experience, expand partnerships with academic and industrial clients, and accelerate development of innovative analytical solutions that bridge research and application.

“Iam honored to join BioTools at such an exciting stage,” said Denis Petrov. “The company’s scientificexcellence and reputation are second to none. My focus will be on expanding our market reach, modernizing customer engagement, and unlocking new growth opportunities.”

About BioTools

BioTools revolutionized life-sciences technology for characterization of the most important therapeutics of our time–chiral small molecules and biologics.  The novel instrumentation and software provide molecular structure information, a drug’s critical quality attribute,which governs safety and efficacy, in a rapid and simplified analysis.

BioTools product offerings, which include chiral-based instrumentation, specialized CRO services, and unique software and accessories, are used by a majority of the world’s top 100 pharmaceutical companies, renowned academic institutions,and government laboratories, including US FDA.

Founded in 2000, BioTools has R&D, sales, customer support, contract research lab and manufacturing facilitiesin West Palm Beach, Florida, and two divisions, BioTools Europe, headquartered in the United Kingdom and BioTools China.  BioTools’ co- founders and products have both been recognized by numerous International Awards.